D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...

"We are grateful to the FDA for their collaboration and review of our complete response package, which included a comprehensive safety assessment of the azenosertib program,” said Kimberly Blackwell, ...

When Dom noticed his bald patch, he resorted to having a hair transplant in Turkey. Here’s how it went – and what you should ...

Overall, the Company believes that the results to date from the TAMARACK study indicate antitumor activity associated with vobra duo in mCRPC as demonstrated by the protocol-specified primary endpoint ...

They are the agent for all our products. They also produced a page using our brand name. They pay us for using our logo. We have contracts ready ... the drug that could help her is approved by the ...

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient's bedside as part of a clinical trial.

Interestingly, this gender-based treatment gap did not significantly vary with patient age, indicating that therapeutic inertia may persist regardless of the woman's stage in life.

The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report provides comprehensive insights about 15+ ...

There was no evidence of clinically significant central adverse events, whereas drowsiness, dry mouth and nausea were reported with comparator agents (levodropropizine, codeine, DL-cloperastine).

Volume of distribution at steady state (L/kg) 187 194 194 Table 2. Changes in cough-related symptoms following treatment with levocloperastine 30, 60 and 120 mg/day for 6 days in patients with ...

A group at NUS Yong Loo Lin School of Medicine (NUS Medicine) has created a nanoparticle technology that provides an ...

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune ...